Valid Ghana · FDA Ghana

NIMENRIX POWDER

MENINGOCOCCAL GROUP; A,C,W-135 & Y

What it does

Group is a medication used to treat various health conditions. It helps manage symptoms and improve overall health.

Commonly used for: specific health condition 1, specific health condition 2

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/HVC/243-02004
Registration date
2024-01-02
Expiry date
2027-05-01
Status
Valid
Active ingredient
MENINGOCOCCAL GROUP; A,C,W-135 & Y
Strength
0.5ML/DOSE
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Pfizer Specialities
Country of origin
-
Manufacturer location
Nsawam Road Nsawam Rd, Accra, Ghana

Source: Food and Drugs Authority · fetched 2026-04-18 08:33:02 · updated 2026-09-25 04:00:08

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About group

Group is a medication used to treat various health conditions. It helps manage symptoms and improve overall health.

What it treats

  • specific health condition 1
  • specific health condition 2

How it works

Group works by affecting certain processes in the body to relieve symptoms and improve health.

Who it's for

This medication is for individuals suffering from specific health conditions as advised by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About meningococcal

Meningococcal vaccines help protect against infections caused by the meningococcal bacteria, which can lead to serious illnesses like meningitis.

What it treats

  • meningitis
  • meningococcal disease

How it works

The vaccine stimulates the immune system to recognize and fight the meningococcal bacteria.

Who it's for

It's recommended for infants, children, and certain adults at risk of meningococcal infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About w-135

W-135 is a medication used to treat various health conditions.

How it works

W-135 works by influencing certain processes in the body to help manage specific conditions.

Who it's for

W-135 is for individuals who have specific medical conditions as determined by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: group

Group is a term that generally refers to a category of medications that share similar pharmacological properties or therapeutic uses. Commonly, groups of drugs are classified based on their mechanism of action, chemical structure, or the conditions they are used to treat. Examples include antihypertensives, analgesics, antibiotics, and antidiabetics. The specific characteristics of a drug group can vary widely depending on the individual drugs within that group, including their efficacy, safety profiles, and side effects.

Dosage

Children: Refer to specific drug monographs for detailed paediatric dosage information, as this will also vary widely among drugs within any given group.

Adults: Refer to specific drug monographs for detailed dosage information, as this will vary widely among drugs within any given group.

Mechanism of action

The mechanism of action for drugs within a group can vary. For example, antihypertensive drugs may work by relaxing blood vessels, reducing heart rate, or decreasing blood volume. Analgesics can work by inhibiting pain pathways in the central nervous system or blocking the production of pain-inducing chemicals. Each individual drug within a group will have its specific pathway and target molecules, such as receptors or enzymes, which are involved in its therapeutic effects.

Pharmacodynamics

Pharmacodynamics describes how a drug affects the body. Within any given drug group, the pharmacodynamics can include the drug's affinity for its target receptors, the efficacy in producing a biological response, and the onset and duration of action. For instance, some analgesics may produce rapid relief of pain, while others may have delayed effects. The dose-response relationship, which indicates how the effects of a drug change with varying doses, is also a crucial aspect of pharmacodynamics.

Pharmacokinetics

Pharmacokinetics encompasses the absorption, distribution, metabolism, and excretion (ADME) of a drug. For drugs within a group, pharmacokinetic parameters can differ significantly. Factors such as bioavailability, half-life, volume of distribution, and clearance rates are important for determining dosing regimens and understanding how long a drug will exert its effects in the body. For example, some antibiotics may be rapidly absorbed and cleared, necessitating more frequent dosing, while others may have extended half-lives allowing for less frequent administration.

Pregnancy

The safety of this drug during pregnancy has not been fully established. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether this drug is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: meningococcal

Meningococcal disease is caused by the bacterium Neisseria meningitidis, which can lead to serious conditions such as meningitis and septicemia. Meningococcal vaccines are used to prevent infections caused by this pathogen. These vaccines stimulate the immune response to produce antibodies against the bacteria, thus reducing the incidence of disease.

Indications

  • Prevention of meningococcal meningitis
  • Prevention of meningococcal septicemia
  • Vaccination in outbreak settings
  • Vaccination for travelers to endemic areas

Dosage

Children: Refer to specific vaccine guidelines for paediatric dosing.

Adults: Refer to specific vaccine guidelines for adult dosing.

Mechanism of action

Meningococcal vaccines work by introducing components of the Neisseria meningitidis bacteria, such as polysaccharide capsules or proteins, into the body. This exposure prompts the immune system to recognize and remember the bacteria, enabling a rapid and effective immune response upon future exposure.

Pharmacodynamics

The pharmacodynamic effect of meningococcal vaccines is the induction of immunological memory, resulting in the production of specific antibodies against the serogroups of Neisseria meningitidis included in the vaccine. The immune response can considerably reduce the risk of developing invasive meningococcal disease.

Pharmacokinetics

Meningococcal vaccines are administered intramuscularly or subcutaneously, where they are absorbed into the systemic circulation. The onset of immunity typically occurs within 2-3 weeks after vaccination, and the duration of protection varies depending on the specific vaccine used. Most vaccines require booster doses to maintain immunity over time.

Contra-indications

  • Severe allergic reaction to any component of the vaccine
  • History of severe allergic reaction (e.g., anaphylaxis) after a previous dose

Adverse effects

  • Fever
  • Headache
  • Fatigue
  • Muscle pain
  • Joint pain
  • Nausea
  • Rash
  • Local reactions at the injection site (pain, redness, swelling)

Interactions

  • Immunosuppressive therapies may reduce vaccine efficacy
  • Concurrent administration with other vaccines is generally acceptable, but consult specific guidelines

Precautions

  • Consider in patients with a history of Guillain-Barré syndrome
  • Use with caution in individuals with moderate or severe acute illness
  • Evaluate the risk of meningococcal disease in populations at increased risk

Pregnancy

The vaccine is recommended during pregnancy if there is a risk of exposure to meningococcal disease.

Breast-feeding

The vaccine is considered safe during breastfeeding.

Storage

Store in a refrigerator (2°C to 8°C). Do not freeze. Protect from light.

Formulations

  • Meningococcal conjugate vaccine (MenACWY)
  • Meningococcal B vaccine (MenB)
  • Meningococcal polysaccharide vaccine

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: w135

W135 is a medication whose specific identity and details are not provided in standard drug references. Based on established pharmacology, it may refer to a compound used for various therapeutic purposes, but without specific details, it is difficult to provide a comprehensive overview.

Dosage

Children: For paediatric dosages, it is essential to consult the BNF for Children or other specialized pediatric references, as no specific dosing information is provided.

Adults: For dosage in adults, refer to the specific medication literature or professional guidelines as no precise dosing information is available for W135.

Mechanism of action

The mechanism of action of W135 is not documented in available literature. Generally, medications classified under similar compounds may function through various pathways, including modulation of neurotransmitter release, inhibition of enzyme activity, or altering receptor sensitivity, but specific details for W135 cannot be determined.

Pharmacodynamics

Pharmacodynamics involves the study of the effects of W135 on the body. Without specific pharmacological data, it is challenging to elucidate the precise effects. Typically, similar compounds may exhibit dose-dependent effects, influencing various physiological systems, but this is speculative.

Pharmacokinetics

Pharmacokinetics describes how the body absorbs, distributes, metabolizes, and excretes a drug. For W135, specific pharmacokinetic parameters are not available. However, standard pharmacokinetic profiles would include absorption rates, peak plasma concentrations, half-life, and clearance mechanisms, but these cannot be specified without further information.

Pregnancy

Consult with a healthcare professional before use. Safety during pregnancy has not been established.

Breast-feeding

Consult with a healthcare professional before use. Minimal data is available on excretion in breast milk.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.